🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This was a Phase 1, open-label, nonrandomized, multicenter study of durvalu...
Status
Completed
Location
Yale Cancer Center
Start Date
2013-12-19
Trial ID
NCT01975831
Treatments Being Tested
Phase II trial evaluating to assess the feasibility and efficacy as first-l...
Status
Completed
Location
Universitätsklinikum Essen
Start Date
2018-08-15
Trial ID
NCT03624231
Treatments Being Tested
This multicentre, open-label, Phase 1b/2 study is designed as a 2 part stud...
Status
Completed
Location
Research Site
Start Date
2015-08-06
Trial ID
NCT02499328
Treatments Being Tested
Durvalumab is a new type of drug for many kinds of cancer. It is considered...
Status
Active Not Recruiting
Location
Campbelltown Hospital
Start Date
2017-03-28
Trial ID
NCT03057106
Treatments Being Tested
A Phase II, Multi-Center, Open-Label Study of Tremelimumab Monotherapy in P...
Status
Completed
Location
Research Site
Start Date
2015-11-02
Trial ID
NCT02527434
Treatments Being Tested
This is an interventional, prospective multicenter, open-label, phase II st...
Status
Completed
Location
Krankenhaus Nordwest
Start Date
2022-05-23
Trial ID
NCT05239169
Treatments Being Tested
To understand efficacy of Durvalumab(MEDI4736)+ Tremelimumab in Metastatic/...
Status
Completed
Location
Department of Internal Medicine, Seoul National University Hospital
Start Date
2017-05-18
Trial ID
NCT03022500
Treatments Being Tested
This is an open-label, Phase 1/2 study to evaluate the safety of durvalumab...
Status
Completed
Location
Research Facility
Start Date
2016-06-24
Trial ID
NCT02735239